Skip to content

Alveolar Macrophage Immunometabolism study

Alveolar Macrophage Immunometabolism study - AMINO study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON54141
Enrollment
20
Registered
2020-10-07
Start date
2021-06-09
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung inflammation pneumonia

Interventions

None listed

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: - Healthy individual between 18 and 60 years of age - Non-smoker or ex-smoker (>2 years) - BMI 17-30 kg.m2

Exclusion criteria

Exclusion criteria: - History of respiratory diseases - History of bleeding disorder - Using anti-inflammatory and/or anticoagulant medication

Design outcomes

Primary

MeasureTime frame
Analysis of immunometabolic pathways in alveolar macrophages of healthy volunteers using an integrative approach (in vitro analysis of the inflammatory and metabolic response to various stimuli and modulators).

Secondary

MeasureTime frame
1. Composition and diversity of the lung microbiome from BAL-fluid. 2. In vivo visualization of the healthy alveolar compartment and airway wall layers using biopsies, Optical Cohorence Tomography (OCT) and Confocal Laser Endomicroscopy (CLE).

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)